NCT01723020 A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01609556 First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors Status COMPLETED Phase PHASE1
NCT01567384 A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies Status WITHDRAWN Phase PHASE1
NCT01562626 Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors Status SUSPENDED Phase PHASE1/PHASE2
NCT01448759 Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel Status COMPLETED Phase NA
NCT01437280 GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers Status WITHDRAWN Phase PHASE1
NCT01409135 A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4 Status COMPLETED Phase PHASE1
NCT01403779 Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer Status COMPLETED Phase PHASE3
NCT01375842 A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01280032 Kypho-IORT: Intraoperative Radiotherapy During Kyphoplasty for Spinal Metastases Status COMPLETED Phase PHASE2
NCT01235897 MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT01180751 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology Status UNKNOWN Phase PHASE3
NCT01155713 Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1